126 Chapter 4 Supplementary Table 3: Continued. Variable Narcolepsy type 1 (N = 194) Narcolepsy type 2 or idiopathic hypersomnia (N = 71) Odds ratio (95% CI) Effect size Corrected p-value Infections & influenza vaccinations N Percentage of N N Percentage of N Infections Total Infection prevalence 149 30.9% 44 63.6% 0.26 (0.13-0.52) 0.2827 0.0020 Flu infection prevalence 149 8.7% 44 4.5% 2.01 (0.44-9.26) 0.0655 0.6062# EBV infection prevalence 149 8.1% 44 22.7% 0.30 (0.12-0.75) 0.1937 0.0273 Other respiratory infection prevalence 149 6.7% 44 18.2% 0.32 (0.12-0.88) 0.1655 0.0707 Other non-respiratory infection prevalence 149 7.4% 44 18.2% 0.36 (0.13-0.96) 0.1521 0.0854 Proportion of flu of all infections 46 28.3% 28 7.1% 5.12 (1.06-24.74) 0.2548 0.0854# Proportion of EBV of all infections 46 26.1% 28 35.7% 0.64 (0.23-1.75) 0.1022 0.5073 Proportion of other respiratory infections of all infections 46 21.7% 28 28.6% 0.69 (0.24-2.04) 0.0772 0.6062 Proportion of non-respiratory infections of all infections 46 23.9% 28 28.6% 0.79 (0.27-2.28) 0.0517 0.6862 Rapid onset after any infection 46 78.3% 28 57.1% 2.70 (0.97-7.53) 0.2241 0.1127 Rapid onset after flu infection 13 100.0% 2 50.0% - 0.6814 0.2556# Influenza vaccinations 0.6862# Total influenza vaccination prevalence 142 31.0% 57 15.8% 2.40 (1.08-5.31) 0.1554 0.0815 0.4926#
RkJQdWJsaXNoZXIy MjY0ODMw